Evidence map›Paper›PMID 30872454›Full record

ArticleJournal of cell science2019

The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity.

Ahmed Elbediwy, Yixiao Zhang, Mathias Cobbaut, Philippe Riou, Ray S Tan, Selene K Roberts, Chris Tynan, Roger George, Svend Kjaer, Marisa L Martin-Fernandez and 3 more

Abstract read
In one paragraph

Article in Journal of cell science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. In silico pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer.Frontiers in cell and developmental biology · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ahmed ElbediwyEpithelial Biology Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Yixiao ZhangProtein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Mathias CobbautProtein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.ORCID 0000-0003-0279-0336
Philippe RiouProtein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Ray S TanProtein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.ORCID 0000-0001-6338-1080
Selene K RobertsCentral Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, Oxford OX11 0QX, UK.
Chris TynanCentral Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, Oxford OX11 0QX, UK.
Roger GeorgeStructural Biology Team, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Svend KjaerStructural Biology Team, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Marisa L Martin-FernandezCentral Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, Oxford OX11 0QX, UK.
Barry J ThompsonEpithelial Biology Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Neil Q McDonaldSignalling and Structural Biology Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK.
Peter J ParkerProtein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK peter.parker@crick.ac.uk.ORCID 0000-0002-6218-2933

Funding

Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI FollowR21CA155911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GREEN, DAMIAN J. · 2011 to 2012
$693k
Cancer Research UK 15683Cancer Research UK FC001130NCI NIH HHS R21 CA155911Wellcome Trust FC001130
6 · The paper itself

Abstract

The elaboration of polarity is central to organismal development and to the maintenance of functional epithelia. Among the controls determining polarity are the PAR proteins, PAR6, aPKCι and PAR3, regulating both known and unknown effectors. Here, we identify FARP2 as a 'RIPR' motif-dependent partner and substrate of aPKCι that is required for efficient polarisation and junction formation. Binding is conferred by a FERM/FA domain-kinase domain interaction and detachment promoted by aPKCι-dependent phosphorylation. FARP2 is shown to promote GTP loading of Cdc42, which is consistent with it being involved in upstream regulation of the polarising PAR6-aPKCι complex. However, we show that aPKCι acts to promote the localised activity of FARP2 through phosphorylation. We conclude that this aPKCι-FARP2 complex formation acts as a positive feedback control to drive polarisation through aPKCι and other Cdc42 effectors.This article has an associated First Person interview with the first author of the paper.

Indexed as

Caco-2 Cellscdc42 GTP-Binding ProteinCell PolarityEpithelial CellsGuanine Nucleotide Exchange FactorsHCT116 CellsHumansPhosphorylationProtein Kinase CTight Junctionscdc42 GTP-Binding ProteinFARP2 protein, humanGuanine Nucleotide Exchange FactorsProtein Kinase CAtypical protein kinase CCdc42FARPPolarity

Identifiers

PMID30872454
PMCPMC6503954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.